Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome.
Saved in:
| Title: | Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome. |
|---|---|
| Authors: | Lin, Hsin-Ching (AUTHOR), Friedman, Michael (AUTHOR), Chang, Hsueh-Wen (AUTHOR), Su, Mao-Chang (AUTHOR), Wilson, Meghan (AUTHOR) |
| Source: | Acta Oto-Laryngologica. Sep2010, Vol. 130 Issue 9, p1070-1076. 7p. 7 Illustrations, 2 Charts. |
| Subjects: | Sleep apnea syndrome treatment, Nasopharynx, Palate surgery, Uvula, Active oxygen in the body, Analysis of variance, Apnea, Medical records, Health outcome assessment, Snoring, Velopharyngeal insufficiency, Polysomnography, Scale items, Treatment effectiveness, Evaluation, Physiology, Surgery |
| Abstract: | Conclusion: Z-palatopharyngoplasty (ZPPP) combined with radiofrequency to the base of tongue (RFBOT) resulted in short-term morbidity only. This study shows the clinical benefits of ZPPP plus RFBOT in patients with moderate/severe obstructive sleep apnea/hypopnea syndrome (OSAHS). Objective: To study the safety and efficacy of ZPPP combined with RFBOT for the treatment of moderate/severe OSAHS. Methods: Charts of all patients with moderate/severe OSAHS who failed or refused CPAP therapy and underwent surgical treatment of ZPPP plus RFBOT were reviewed. The subjective symptoms and objective polysomnographic parameters were collected preoperatively and postoperatively. Postoperative morbidity was recorded. Results: Forty-three OSAHS patients (2 females, 41 males, mean age 39 years) had full data and a minimum 6 month follow-up to assess efficacy. Intraoperative, short-term, and long-term morbidities are reported. No long-term velopharyngeal insufficiency was encountered. The classical success rate was 60.5% (26/43). Six months after the treatment, the mean Epworth sleepiness scale changed from 12.8 ± 5.1 to 10.0 ± 4.3 ( p = 0.002). The apnea/hypopnea index (/h), lowest oxygen saturation (%), and bed partner assessed snoring visual analog scale (0–10) changed from 51.5 ± 25.4 to 23.4 ± 24.7, 75.5 ± 10.4 to 82.1 ± 10.9, and 8.4 ± 1.6 to 2.9 ± 1.6, respectively (all p < 0.0001, paired t test). [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Oto-Laryngologica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Conclusion: Z-palatopharyngoplasty (ZPPP) combined with radiofrequency to the base of tongue (RFBOT) resulted in short-term morbidity only. This study shows the clinical benefits of ZPPP plus RFBOT in patients with moderate/severe obstructive sleep apnea/hypopnea syndrome (OSAHS). Objective: To study the safety and efficacy of ZPPP combined with RFBOT for the treatment of moderate/severe OSAHS. Methods: Charts of all patients with moderate/severe OSAHS who failed or refused CPAP therapy and underwent surgical treatment of ZPPP plus RFBOT were reviewed. The subjective symptoms and objective polysomnographic parameters were collected preoperatively and postoperatively. Postoperative morbidity was recorded. Results: Forty-three OSAHS patients (2 females, 41 males, mean age 39 years) had full data and a minimum 6 month follow-up to assess efficacy. Intraoperative, short-term, and long-term morbidities are reported. No long-term velopharyngeal insufficiency was encountered. The classical success rate was 60.5% (26/43). Six months after the treatment, the mean Epworth sleepiness scale changed from 12.8 ± 5.1 to 10.0 ± 4.3 ( p = 0.002). The apnea/hypopnea index (/h), lowest oxygen saturation (%), and bed partner assessed snoring visual analog scale (0–10) changed from 51.5 ± 25.4 to 23.4 ± 24.7, 75.5 ± 10.4 to 82.1 ± 10.9, and 8.4 ± 1.6 to 2.9 ± 1.6, respectively (all p < 0.0001, paired t test). [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00016489 |
| DOI: | 10.3109/00016481003606240 |
